DE69322201D1 - Selbstklebendes Matrixsystem für die transdermal-gesteuerte Abgabe von Piribedil - Google Patents

Selbstklebendes Matrixsystem für die transdermal-gesteuerte Abgabe von Piribedil

Info

Publication number
DE69322201D1
DE69322201D1 DE69322201T DE69322201T DE69322201D1 DE 69322201 D1 DE69322201 D1 DE 69322201D1 DE 69322201 T DE69322201 T DE 69322201T DE 69322201 T DE69322201 T DE 69322201T DE 69322201 D1 DE69322201 D1 DE 69322201D1
Authority
DE
Germany
Prior art keywords
piribedil
self
transdermally
matrix system
controlled delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69322201T
Other languages
English (en)
Other versions
DE69322201T2 (de
Inventor
Alain Cuine
Isabelle Rault
Francoise Arnaud
Olivier Crambes
Gerald Pichon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of DE69322201D1 publication Critical patent/DE69322201D1/de
Publication of DE69322201T2 publication Critical patent/DE69322201T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Addiction (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69322201T 1992-05-19 1993-05-18 Selbstklebendes Matrixsystem für die transdermal-gesteuerte Abgabe von Piribedil Expired - Fee Related DE69322201T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9206037A FR2691361B1 (fr) 1992-05-19 1992-05-19 Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.

Publications (2)

Publication Number Publication Date
DE69322201D1 true DE69322201D1 (de) 1999-01-07
DE69322201T2 DE69322201T2 (de) 1999-06-24

Family

ID=9429912

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322201T Expired - Fee Related DE69322201T2 (de) 1992-05-19 1993-05-18 Selbstklebendes Matrixsystem für die transdermal-gesteuerte Abgabe von Piribedil

Country Status (11)

Country Link
EP (1) EP0571264B1 (de)
JP (1) JPH0632738A (de)
AT (1) ATE173623T1 (de)
AU (1) AU656266B2 (de)
CA (1) CA2096511A1 (de)
DE (1) DE69322201T2 (de)
DK (1) DK0571264T3 (de)
ES (1) ES2127259T3 (de)
FR (1) FR2691361B1 (de)
NZ (1) NZ247648A (de)
ZA (1) ZA933508B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675383B1 (fr) * 1991-04-18 1995-05-12 Bernard Aranda Utilisation d'un medicament pour la fabrication d'un medicament destine au traitement des vessies hyperactives ou instables.
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
FR2744130B1 (fr) * 1996-01-31 1998-03-20 Atohaas Holding Cv Composition adhesive pour materiaux en (co) polymere (meth) acrylique
CN103373991A (zh) * 2013-07-12 2013-10-30 安徽安腾药业有限责任公司 高纯度、高收率制备吡贝地尔的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
WO1989007951A1 (en) * 1988-02-26 1989-09-08 Riker Laboratories, Incorporated Transdermal estradiol delivery system
FR2664815B1 (fr) * 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
GB9102089D0 (en) * 1991-01-31 1991-03-13 Johnson & Johnson Medical Net wound dressings

Also Published As

Publication number Publication date
AU3860793A (en) 1993-11-25
EP0571264A1 (de) 1993-11-24
FR2691361A1 (fr) 1993-11-26
NZ247648A (en) 1995-01-27
DE69322201T2 (de) 1999-06-24
ATE173623T1 (de) 1998-12-15
AU656266B2 (en) 1995-01-27
EP0571264B1 (de) 1998-11-25
ZA933508B (en) 1993-12-10
JPH0632738A (ja) 1994-02-08
CA2096511A1 (fr) 1993-11-20
DK0571264T3 (da) 1999-08-09
FR2691361B1 (fr) 1994-07-08
ES2127259T3 (es) 1999-04-16

Similar Documents

Publication Publication Date Title
FI954989A (fi) Lääkelaastari
DE68910867T2 (de) Matrix für die transdermale Abgabe von Arzneimitteln.
BR9407238A (pt) Dispositivo implantável de fornecimento de droga
MX9203755A (es) Dispositivo de suministro iontoforetico de drogas o agentes terapeuticos, dotado de un adhesivo de electrotransporte.
PT840621E (pt) Adesivos com hormonas
DK288987D0 (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
FI955215A (fi) Hallitusti vapauttavat oksibutyniinivalmisteet
DE68904124D1 (de) System fuer die rufzuteilung von aufzuegen, basierend auf den wartezeiten unter verwendung von spitzenverkehrsvorhersagen.
ATE164059T1 (de) Wundverband
DE3880984T2 (de) Emulgator enthaltender emmulsionssprengstoff.
DE69322201T2 (de) Selbstklebendes Matrixsystem für die transdermal-gesteuerte Abgabe von Piribedil
DE69110781T2 (de) Selbstklebendes Matrixsystem für transdermal gesteuerte Abgabe von Piribedil.
DE3673171D1 (de) Loesliches, vernetzbares acrylatcopolymerisat, verfahren zu seiner herstellung und ueberzugsmittel auf der basis des acrylatcopolymerisats.
FI101855B1 (fi) Menetelmä asetatsolamidia jatkuvasti vapauttavan asetatsolamidivalmisteen valmistamiseksi
DE3851994D1 (de) Blasenfreie, druckempfindliche Klebefolie.
SU978385A1 (ru) Система селективного вызова
DE59712215D1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination
IT226162Z2 (it) Staffa di supporto per fermaglio, per orecchini e simili.
ATE61994T1 (de) Verabreichungsanordnung mit geregelter menge.
IT8422131A0 (it) Struttura di supporto a mensola per vigneti, frutteti e simili.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

8339 Ceased/non-payment of the annual fee